KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Short-term Investments: 2018-2024

Historic Short-term Investments for Adaptive Biotechnologies (ADPT) over the last 7 years, with Dec 2024 value amounting to $174.4 million.

  • Adaptive Biotechnologies' Short-term Investments fell 23.15% to $157.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $157.7 million, marking a year-over-year decrease of 23.15%. This contributed to the annual value of $174.4 million for FY2024, which is 38.02% down from last year.
  • As of FY2024, Adaptive Biotechnologies' Short-term Investments stood at $174.4 million, which was down 38.02% from $281.3 million recorded in FY2023.
  • Over the past 5 years, Adaptive Biotechnologies' Short-term Investments peaked at $564.8 million during FY2020, and registered a low of $174.4 million during FY2024.
  • Moreover, its 3-year median value for Short-term Investments was $281.3 million (2023), whereas its average is $288.0 million.
  • In the last 5 years, Adaptive Biotechnologies' Short-term Investments tumbled by 62.11% in 2021 and then surged by 90.74% in 2022.
  • Adaptive Biotechnologies' Short-term Investments (Yearly) stood at $564.8 million in 2020, then slumped by 62.11% to $214.0 million in 2021, then skyrocketed by 90.74% to $408.2 million in 2022, then crashed by 31.07% to $281.3 million in 2023, then tumbled by 38.02% to $174.4 million in 2024.